Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Status: Enrolling, Phase II
Updated: 4/30/2018
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Status: Enrolling, Phase II
Updated: 4/30/2018
316
mi
from 43215
Toronto,
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases, Other Clinical Trial
Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007)
Status: Enrolling, Phase I
Updated: 6/13/2017
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Health Winchester Medical Center
264
mi
from 43215
Winchester, VA
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
444
mi
from 43215
Bridgewater, NJ
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
418
mi
from 43215
Camden, NJ
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
278
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
989
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
493
mi
from 43215
Macon, GA
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
1109
mi
from 43215
New Braunfels, TX
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
2075
mi
from 43215
Roseburg, OR
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
617
mi
from 43215
Saint Paul, MN
Click here to add this to my saved trials
Acute Coronary Syndromes Clinical Trial
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Merck Sharp & Dohme
9459
mi
from 43215
North Ryde,
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Congenital Afibrinogenemia Clinical Trial
Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Patients With Congenital Afibrinogenemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Northshore Long Island Jewish Medical Center
493
mi
from 43215
New Hyde Park, NY
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth (Consent only)
469
mi
from 43215
Middletown, NJ
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Bergen (Consent only)
476
mi
from 43215
Montvale, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
4502
mi
from 43215
'Aiea, HI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
494
mi
from 43215
Anchorage, AL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2070
mi
from 43215
Antioch, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
304
mi
from 43215
Aurora, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2015
mi
from 43215
Bainbridge Island, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1970
mi
from 43215
Bellflower, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2097
mi
from 43215
Berkeley, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1469
mi
from 43215
Bozeman, MT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
244
mi
from 43215
Caro, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
471
mi
from 43215
Cedar Rapids, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
138
mi
from 43215
Charleston, WV
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
170
mi
from 43215
Chelsea, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
306
mi
from 43215
Clyde, NC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
679
mi
from 43215
Council Bluffs, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
31
mi
from 43215
Crestview Hills, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
402
mi
from 43215
Cumming, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
64
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
314
mi
from 43215
Decatur, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
654
mi
from 43215
Duluth, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
194
mi
from 43215
East China Township, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
546
mi
from 43215
Eau Claire, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1247
mi
from 43215
Edwards, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
758
mi
from 43215
El Dorado, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
333
mi
from 43215
Eureka, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
92
mi
from 43215
Fairfield, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
857
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
437
mi
from 43215
Florence, SC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
604
mi
from 43215
Fort Dodge, IA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2018
mi
from 43215
Gig Harbor, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1648
mi
from 43215
Gilbert, AZ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
288
mi
from 43215
Glenview, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
248
mi
from 43215
Grand Rapids, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
918
mi
from 43215
Grapevine, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
849
mi
from 43215
Great Bend, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2109
mi
from 43215
Greenbrae, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
85
mi
from 43215
Greenville, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
403
mi
from 43215
Greenwood, SC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
442
mi
from 43215
Hamilton, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
872
mi
from 43215
Hays, KS
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
336
mi
from 43215
Highland Park, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
838
mi
from 43215
Houma, LA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
609
mi
from 43215
Independence, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
288
mi
from 43215
Joliet, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
810
mi
from 43215
Kissimmee, FL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
493
mi
from 43215
Lake Success, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1167
mi
from 43215
Lakewood, CO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2004
mi
from 43215
Lakewood, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
206
mi
from 43215
Lansing, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
329
mi
from 43215
Lewisburg, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
721
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1130
mi
from 43215
Lubbock, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
273
mi
from 43215
Lynchburg, VA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
404
mi
from 43215
Macomb, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
493
mi
from 43215
Macon, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
232
mi
from 43215
Marlette, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
488
mi
from 43215
Marshfield, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2087
mi
from 43215
Martinez, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
115
mi
from 43215
Maumee, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
345
mi
from 43215
Mechanicsville, VA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
529
mi
from 43215
Minocqua, WI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
125
mi
from 43215
Muncie, IN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
295
mi
from 43215
Naperville, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Nassau Bay, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1963
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
762
mi
from 43215
Norfolk, NE
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
177
mi
from 43215
Novi, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2099
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
633
mi
from 43215
Olathe, KS
Click here to add this to my saved trials